Troy A. Ignelzi - Chief Financial Officer at Karuna Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Troy A. Ignelzi since 20 Sep 2025

Reported holdings for Troy A. Ignelzi in Karuna Therapeutics, Inc.

Form 4 holding Chief Financial Officer

Karuna Therapeutics, Inc.

Security class
Common Stock
Shares / value
30,487
Estimated value
$9,658,586
Report date
22 Aug 2023
Price
$316.81
Ownership
Direct
Form 4 holding Chief Financial Officer

Karuna Therapeutics, Inc.

Security class
Option (right to buy)
Shares / value
93,226
Estimated value
$8,604,760
Report date
22 Aug 2023
Price
$92.30
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Troy A. Ignelzi in Karuna Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .